Investors
- VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF SERUM-FREE RABIES VACCINE ACHIEVED SATISFACTORY PHASE RESULTS
-
2023-09-20
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
-
2023-09-05
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
-
2023-09-05
- VOLUNTARY ANNOUNCEMENT - THE APPROVAL FOR THE ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES FROM THE CSRC
-
2023-08-30
- VOLUNTARY ANNOUNCEMENT - INITIATION OF RANDOMIZED, BLINDED AND COMPARABLE VACCINE-CONTROLLED PHASE III CLINICAL TRIAL OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE
-
2023-08-29
- 2023 INTERIM REPORT
-
2023-08-29
- NOTICE OF BOARD MEETING
-
2023-08-17
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
-
2023-08-01
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
-
2023-07-03
- VOLUNTARY ANNOUNCEMENT - BIVALENT mRNA VACCINE AGAINST COVID-19 VARIANTS DELTA AND OMICRON BA.5 OBTAINED CLINICAL TRIAL APPROVALS FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION
-
2023-06-29
- VOLUNTARY ANNOUNCEMENT - APPLICATION ACCEPTED FOR CLINICAL TRIAL OF HUMAN RABIES mRNA VACCINE AGAINST RABIES VIRUS
-
2023-06-12
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
-
2023-06-01
- VOLUNTARY ANNOUNCEMENT MAJOR RESULTS OF A DOMESTIC STUDY ON PROTECTIVE EFFICACY OF COVID-19 VARIANT OMICRON BA.5 mRNA VACCINE LVRNA012
-
2023-06-01
- POLL RESULTS OF THE ANNUAL GENERAL MEETING, THE 2023 SECOND CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND THE 2023 SECOND H SHARE CLASS MEETING HELD ON MAY 28, 2023
-
2023-05-28
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
-
2023-05-04
- POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, THE CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND THE H SHARE CLASS MEETING HELD ON APRIL 28, 2023
-
2023-04-28
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2023 SECOND H SHARE CLASS MEETING TO BE HELD ON MAY 28, 2023
-
2023-04-21
- FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 28, 2023
-
2023-04-21
- NOTICE OF 2022 ANNUAL GENERAL MEETING
-
2023-04-21
- 2022 CIRCULAR OF ANNUAL GENERAL MEETING
-
2023-04-21
- FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE 2023 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON APRIL 28, 2023
-
2023-04-11
- NOTICE OF H SHARE CLASS MEETING
-
2023-04-11
- NOTICE OF EXTRAORDINARY GENERAL MEETING
-
2023-04-11
- PROPOSED ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES UNDER SPECIFIC MANDATE, NOTICE OF THE EXTRAORDINARY GENERAL MEETING AND NOTICE OF THE H SHARE CLASS MEETING
-
2023-04-11
- CLOSURE OF REGISTER OF MEMBERS
-
2023-04-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
-
2023-04-03
- NOTICE OF BOARD MEETING
-
2023-03-17
- VOLUNTARY ANNOUNCEMENT - TETRAVALENT MENINGOCOCCAL CONJUGATE VACCINE CANDIDATE OFFICIALLY COMMENCED CLINICAL TRIAL
-
2023-03-17
- INSIDE INFORMATION-(1) PROPOSED ISSUANCE OF UNLISTED RMB DENOMINATED ORDINARY SHARES (2) PROPOSED AUTHORIZATIONS TO THE BOARD RELATING TO THE PROPOSED ISSUANCE (3) PROPOSED EGM AND CLASS MEETINGS
-
2023-03-08
- PROFIT WARNING
-
2023-03-03
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
-
2023-03-01
- VOLUNTARY ANNOUNCEMENT - MRNA COVID-19 VACCINE CANDIDATES AGAINST COVID-19 VARIANTS AND ORIGINAL STRAIN OBTAINED CLINICAL TRIAL APPROVALS IN PAKISTAN
-
2023-02-15
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
-
2023-02-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
-
2023-01-06
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
-
2023-01-06
- (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
-
2023-01-06
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
-
2022-12-01
- Next Day Disclosure Return
-
2022-11-02
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
-
2022-11-01
- VOLUNTARY ANNOUNCEMENT —— EV71-CA16 BIVALENT HFMD VACCINE CANDIDATE OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
-
2022-10-31
- PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
-
2022-10-28
- VOLUNTARY ANNOUNCEMENT —— FREEZE-DRIED HUMAN RABIES VACCINE CANDIDATE (SERUM-FREE VERO CELL) OBTAINED THE CLINICAL TRIAL APPROVAL ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
-
2022-10-24
- Announcement of Allotment Results
-
2022-10-05
- Articles of Association
-
2022-10-05
- GLOBAL OFFERING
-
2022-09-23
- GLOBAL OFFERING
-
2022-09-23
- GREEN APPLICATION FORM
-
2022-09-23